Aeterna Zentaris Inc. (AEZS) SEC Filing 6-K Foreign Issuer Report for the period ending Tuesday, May 9, 2023

Aeterna Zentaris Inc.

CIK: 1113423 Ticker: AEZS

View differences made from one to another to evaluate Aeterna Zentaris Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeterna Zentaris Inc..


Assess how Aeterna Zentaris Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Aeterna Zentaris Inc. provided additional information to their SEC Filing as exhibits

Ticker: AEZS
CIK: 1113423
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001493152-23-015971
Submitted to the SEC: Tue May 09 2023 5:00:20 PM EST
Accepted by the SEC: Tue May 09 2023
Period: Tuesday, May 9, 2023
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: